Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Diasome Pharmaceuticals to Present at the 68th Annual American Diabetes Association Meeting

Abstract:
Diasome Pharmaceuticals, a clinical stage diabetes therapeutics company, announced today that four abstracts were accepted for publication at the 68th Annual Meeting of the American Diabetes Association, being held June 6 through June 10 at the Moscone Convention Center in San Francisco, Ca.

Diasome Pharmaceuticals to Present at the 68th Annual American Diabetes Association Meeting

CONSHOHOCKEN, PA | Posted on May 20th, 2008

All of the abstracts highlight HDV-Insulin, the Company's proprietary oral and injectable insulin products. The following will be presented as posters from Saturday, June 7 through Monday, June 9 in Hall D:

* A 2-Week Randomized Active Comparator Study of Two HDV-Insulin Routes (SC and Oral) and SC Human Insulin in Patients with Type 1 Diabetes Mellitus. Sherwyn Schwartz, MD, Blair Geho, MD, PhD, Len Rosenberg, PhD, RPh, John Lau. Diabetes and Glandular Research Center, San Antonio, TX, and Diasome Pharmaceuticals, Conshohocken, PA.
* Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients with Type 2 Diabetes Mellitus. Sherwyn Schwartz, MD, Blair Geho, MD, PhD, Len Rosenberg, PhD, RPh, John Lau. Diabetes and Glandular Research Center, San Antonio, TX, and Diasome Pharmaceuticals, Conshohocken, PA.
* Hepatic-Directed Vesicle Insulin: Evaluation of a Novel Oral and Subcutaneous Insulin Delivery System in Animal Models of Diabetes. Blair Geho, MD, PhD, John Lau, Len Rosenberg, PhD, RPh, Diasome Pharmaceuticals, Conshohocken, PA.

In addition, presenters will be on hand Saturday, June 7, from 11:30 a.m. to 1:30 p.m., and on Monday, June 9, from noon to 2 p.m. for questions and discussions with attendees.

Diasome is developing Oral HDV-Insulin, a nanotechnology-based cell targeting system for the improved treatment of diabetes mellitus. Diasome's therapies have been tested in more than 100 subjects to date. The Company is preparing to conduct longer term clinical trials in 2008 after having held an end of Phase II meeting with the FDA in 2007.

####

About Diasome Pharmaceuticals, Inc.
Diasome Pharmaceuticals, Inc. is a venture-backed biopharmaceutical company focused on novel insulin-based therapies for the improved treatment of diabetes. The Company was formed in 2004 and has completed multiple Phase II human studies of HDV-Insulin, its proprietary insulin targeting system. Diasome uses a unique, nano-technology based cell targeting system to preferentially deliver insulin to the hepatocytes in the liver. This technology has led to the development of Oral HDV-Insulin, an advanced oral delivery system for insulin. For more information, please visit Diasome’s website at www.Diasome.com.

About the American Diabetes Association

The American Diabetes Association (ADA) is the nation’s premier voluntary health organization supporting diabetes research, information and advocacy. Founded in 1940, the Association's mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. The Association’s commitment to research is reflected through its scientific meetings; education and provider recognition programs; and its Research Foundation and Nationwide Research Program, which fund breakthrough studies looking into the cure, prevention, and treatment of diabetes and its complications. www.Diabetes.org

For more information, please click here

Contacts:
Gregory FCA
Theresa Murray
610-642-8253 x164

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Piezoelectricity in a 2-D semiconductor: Berkeley Lab researchers discovery of piezoelectricty in molybdenum disulfide holds promise for future MEMS December 22nd, 2014

Quantum physics just got less complicated December 22nd, 2014

Enzyme Biosensor Used for Rapid Measurement of Drug December 22nd, 2014

Universality of charge order in cuprate superconductors: Charge order has been established in another class of cuprate superconductors, highlighting the importance of the phenomenon as a general property of these high-Tc materials December 22nd, 2014

Nanomedicine

Enzyme Biosensor Used for Rapid Measurement of Drug December 22nd, 2014

Creation of 'Rocker' protein opens way for new smart molecules in medicine, other fields December 18th, 2014

Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014

Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial December 17th, 2014

Announcements

Piezoelectricity in a 2-D semiconductor: Berkeley Lab researchers discovery of piezoelectricty in molybdenum disulfide holds promise for future MEMS December 22nd, 2014

Quantum physics just got less complicated December 22nd, 2014

Enzyme Biosensor Used for Rapid Measurement of Drug December 22nd, 2014

Universality of charge order in cuprate superconductors: Charge order has been established in another class of cuprate superconductors, highlighting the importance of the phenomenon as a general property of these high-Tc materials December 22nd, 2014

Events/Classes

Bruker Introduces BioScope Resolve High-Resolution BioAFM System: Featuring PeakForce Tapping for Quantitative Bio-Mechanical Property Mapping December 16th, 2014

TCL Launches World’s Most Advanced TV in the World’s Largest Market: New Quantum Dot TVs with Color IQ™ Optics Deliver OLED-Quality Color at a Fraction of the Price December 15th, 2014

Stanford team combines logic, memory to build a 'high-rise' chip: Today circuit cards are laid out like single-story towns; Futuristic architecture builds layers of logic and memory into skyscraper chips that would be smaller, faster, cheaper -- and taller December 15th, 2014

PETA science consortium to present at Society for Risk Analysis meeting December 10th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE